These references are considered pivotal in the Australian context. Many have been referred to in the website.
Anti-Discrimination Board of New South Wales (ADBNSW). C-Change - Report of the enquiry into hepatitis C related discrimination. 2001; Sydney: Anti-Discrimination Board of New South Wales.
Australian Institute of Health and Welfare. Statistics on drug use in Australia 2002. (Cat. No. PHE 43 (Drug Statistics Series no. 12)) 2003; Canberra: Australian Institute of Health and Welfare.
Australian Bureau of Statistics, Australian Institute of Health and Welfare. The health and welfare of Australia's Aboriginal and Torres Strait Islander people 2003; Canberra: Australian Institute of Health and Welfare and the Australian Bureau of Statistics.
Australian Institute for Health and Welfare Canberra. 2004 National Drug Strategy Household Survey: first results. 2005; Available at: www.aihw.gov.au/publications/phe/ndshs04/ndshs04.pdf
Charles, P.G.P., Angus, P.W., Sasadeusz, J.J. et al. Management of healthcare workers after occupational exposure to hepatitis C virus. Medical Journal of Australia 2003; 179, 153-157.
Commonwealth of Australia. National Hepatitis C Strategy 2005-2008. 2005; Canberra.
Communicable Diseases Network of Australia (CDNA), National Public Health Partnership (NPHP), and Australian Health Ministers' Advisory Council (AHMAC). Infection control guidelines for the prevention of transmission of infectious diseases in the health care setting 2004; Canberra: Australian Government, Department of Health and Ageing.
Crofts, N., Dore, G. and Locarnini, S.A. (Eds.). Hepatitis C: An Australian Perspective 2001; Melbourne: IP Communications.
Dev, A., Sundararajan, V. and Sievert, W. Ethnic and cultural determinants influence risk assessment for hepatitis C acquisition. Journal of Gastroenterology and Hepatology 2004; 19: 792-798.
Dolan K., MacDonald, M., Silins, E. et al. Needle and syringe programs: a review of the evidence. 2005; Canberra: Australian Government Department of Health and Aging.
Dore, G. Removal of liver biopsy – what will it achieve? Australian Hepatitis Chronicle 2006; issue 16 (October): 4-5.
Dore G.J., Law M., MacDonald M. et al. Epidemiology of Hepatitis C virus infection in Australia. Journal of Clinical Virology 2003; 26(2):171-84.
Farrell, G. C. Hepatitis C, other liver disorders, and liver health: A practical guide. 2002; Sydney, Australia: MacLennan and Petty Pty Limited.
Fried, M. W., Shiffman, M., Reddy, K. R. et al.. Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection. New England Journal of Medicine, 347(13), 975-982.
Gifford, S.M., O’Brien, M.L., Bammer, G. et al. Australian women’s experiences of living with hepatitis C: results of a cross-sectional survey. Journal of Gastroenterology and Hepatology 2003; 18(12): 1329-1331.
Hadziyannis, S. J., Sette, H., Morgan, T. R. et al. & PEGASYS International Study Group. Peginterferon-alfa 2a and ribavirin combination therapy in chronic hepatitis C: A randomized study of treatment duration and ribavirin dose. Annals of Internal Medicine 2004; 140(5), 346-355.
Hellard, M.E., Nguyen, O.K., Guy, R.J. et al. The prevalence and risk behaviours associated with the transmission of blood-borne viruses among ethnic-Vietnamese injecting drug users. Australian and New Zealand Journal of Public Health 2006; 30(6): 519-525.
Hepatitis C Council of Queensland. The Box Project Report: Results from the General Community Hepatitis C Needs Assessment and an Audit and Education and Training Needs Assessment, unpublished 2002: Hepatitis C Council of Queensland, Brisbane.
Khan, M., Farrell, G., Byth, K. et al. Which patients with hepatitis C develop liver complications? Hepatology 2000; 31: 513-520.
Maher, L., Chant, K., Jalaudin, B. et al. Risk behaviours and antibody hepatitis B and C prevalence among IDUs in south-western Sydney, Australia. Journal of Gastroenterology and Hepatology 2004; 19: 1114 –1120.
Manns, M. P., McHutchison, J. G., Gordon, S. C. et al. Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: A randomised trial. Lancet 2001; 358(9286): 958-965.
Miller, K.P. and Mahamati. Not Round Here; Affirming Diversity, Challenging Homophobia Rural Service Providers Training Manual 2000; Human Rights and Equal Opportunity Commission [HREOC], Sydney.
Mok, J., Pembrey, L., Tovo, P-A., Newell M-L and for the European Paediatric Hepatitis C Virus Network. When does mother to child transmission of hepatitis C virus occur? Archives of Diseases in Childhood. Fetal Neonatal Education 2005; 90:156-60.
National Centre in HIV Epidemiology and Clinical Research. Hepatitis C Virus Projections Working Group: Estimates and projections of the Hepatitis C virus epidemic in Australia 2006. 2006; Sydney.
National Health and Medical Research Council. The Australian Immunisation Handbook – 8th Edition. 2003; Canberra. http://www9.health.gov.au/immhandbook/pdf/handbook.pdf
Ollis, D. and Mitchell, A. Talking Sexual Health: a teaching and learning resource for secondary schools. Australian Research Centre in Sex, Health and Society at La Trobe University for The Australian National Council on AIDS, Hepatitis and Related Disease (ANCAHRD). 2001; Melbourne.
Thompson, S.C., Boughton, C.R. & Dore, G.J. (2003). Blood-borne viruses and their survival in the environment: is public concern about community needlestick exposures justified? Australia and New Zealand Journal of Public Health; 27(6): 602-607.
Treloar, C. J. and Hopwood, M. N. Infection control in the context of hepatitis C disclosure: Implications for education of healthcare professionals. Education for Health 2004; 17(2), 183-191.
Shoobridge J, Vincent N, Allsop S, Biven A. Using rapid assessment methodology to examine injecting drug use in an Aboriginal community. A collaborative project conducted by the Aboriginal Drug and Alcohol Council, the Lower Murray Nungas Club, and the National Centre for Education and Training on Addiction. 1998; National Centre for Education and Training on Addiction and the Aboriginal Drug and Alcohol Council.
World Health Organisation. Weekly Epidemiological Record. No 49, 10 December 1999. Available from URL:http://www.who.int/mediacentre/factsheets/fs164/en/index.html